Hot Off The Press: Merck’s Acquisitions 1st Half 2026

Issa and Chinmay cover Merck Group and Merck & Co.'s acquisitions in 1st Half of 2026. Merck's buying spree has included JSR Life Sciences, Bio-Techne, Terns Pharmaceuticals, and Cidara Therapeutics. What do these acquisitions mean for Merck and the industry? Listen in.